CN Patent

CN114907365B — 一种流感病毒抑制剂及其用途

Assigned to Yangtze River Pharmaceutical Group Co Ltd · Expires 2023-12-01 · 2y expired

What this patent protects

本发明提供了一类式I所示的具有作为流感病毒复制抑制剂的新化合物及其在治疗流感中的用途，具体涉及作为流感病毒帽依赖性核酸内切酶抑制剂。

USPTO Abstract

本发明提供了一类式I所示的具有作为流感病毒复制抑制剂的新化合物及其在治疗流感中的用途，具体涉及作为流感病毒帽依赖性核酸内切酶抑制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN114907365B
Jurisdiction
CN
Classification
—
Expires
2023-12-01
Drug substance claim
No
Drug product claim
No
Assignee
Yangtze River Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.